Vericel (VCEL) Operating Leases (2019 - 2026)
Vericel (VCEL) reported Operating Leases of $95.0 million for Q1 2026, down 4.62% on a YoY basis from $99.6 million in Q1 2025, and down 1.91% sequentially from $96.9 million in Q4 2025.
Vericel (VCEL) Operating Leases (2019 - 2026) Analysis & Trends
Vericel (VCEL) has 8 years of Operating Leases data on file, last reported at $95.0 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Leases fell 4.62% year-over-year to $95.0 million; the trailing twelve-month figure through Mar 2026 stood at $95.0 million (down 4.62% YoY), and the FY2025 full-year result was $96.9 million, up 8.15% from the prior year.
- Operating Leases retreated to $95.0 million in Q1 2026, from $96.9 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $99.6 million in Q1 2025 to a low of $43.3 million in Q4 2022.
- A 5-year average of $78.1 million and a median of $86.0 million in 2025 frame the typical range for Operating Leases.
- Across the five-year window, Operating Leases declined 13.78% in 2022 and soared 96.56% in 2024, its largest moves.
- Tracing VCEL's Operating Leases over 5 years: stood at $43.3 million in 2022, then jumped by 89.18% to $81.9 million in 2023, then increased by 9.45% to $89.6 million in 2024, then advanced by 8.15% to $96.9 million in 2025, then dropped by 1.91% to $95.0 million in 2026.
- Business Quant data shows VCEL's Operating Leases at $95.0 million in Q1 2026, $96.9 million in Q4 2025, and $98.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 95.04 Mn |
| Dec 31, 2025 | 96.89 Mn |
| Sep 30, 2025 | 98.67 Mn |
| Jun 30, 2025 | 86.01 Mn |
| Mar 31, 2025 | 99.65 Mn |
| Dec 31, 2024 | 89.59 Mn |
| Sep 30, 2024 | 91.34 Mn |
| Jun 30, 2024 | 95.59 Mn |
| Mar 31, 2024 | 92.15 Mn |
| Dec 31, 2023 | 81.86 Mn |
| Sep 30, 2023 | 85.00 Mn |
| Jun 30, 2023 | 83.38 Mn |
| Mar 31, 2023 | 46.88 Mn |
| Dec 31, 2022 | 43.27 Mn |
| Sep 30, 2022 | 48.12 Mn |
| Jun 30, 2022 | 48.18 Mn |
| Mar 31, 2022 | 46.07 Mn |
| Dec 31, 2021 | 50.18 Mn |
| Sep 30, 2021 | 48.54 Mn |
| Jun 30, 2021 | 46.99 Mn |